The weekly litigation news digest is live. Subscribe now

New Use Of An Anti-Cd303 Transmembrane Protein Antibody - EP3390452

The patent EP3390452 was granted to Laboratoire Franais DU Fractionnement ET DES Biotechnologies on May 26, 2021. The application was originally filed on Dec 16, 2016 under application number EP16826758A. The patent is currently recorded with a legal status of "Revoked".

EP3390452

LABORATOIRE FRANAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES
Application Number
EP16826758A
Filing Date
Dec 16, 2016
Status
Revoked
May 5, 2023
Publication Date
May 26, 2021
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

STRAWMANFeb 28, 2022VOSSIUS & PARTNER PATENTANWALTE RECHTSANWALTE MBBADMISSIBLE

Patent Citations (10) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
INTERNATIONAL-SEARCH-REPORTWO0136487
INTERNATIONAL-SEARCH-REPORTWO2009138489
INTERNATIONAL-SEARCH-REPORTWO2012080642
INTERNATIONAL-SEARCH-REPORTWO2015095143
OPPOSITIONWO2012080642
OPPOSITIONWO2014093396
OPPOSITIONWO2015095143
OPPOSITIONWO2016156449
OPPOSITIONWO2016156450
OPPOSITIONWO2017103521

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents